NCT00575146View on ClinicalTrials.gov

Ketogenic Diet for Recurrent Glioblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Recurrent Glioblastoma
Interventions
DIETARY_SUPPLEMENT

TAVARLIN

ketogenic diet, dietary supplementary products provided by TAVARLIN

Trial Locations (2)

60528

Senckenberg Institute of Neurooncology, Frankfurt

72076

Department of General Neurology and Hertie-Institute of Clinical Brain Research, University of Tuebingen, Tübingen

All Listed Sponsors
collaborator

Evomed MedizinService GmbH

UNKNOWN

lead

University Hospital Tuebingen

OTHER

NCT00575146 - Ketogenic Diet for Recurrent Glioblastoma | Biotech Hunter | Biotech Hunter